Share on StockTwits

Shares of CME Group (NYSE:CME) have been given an average recommendation of “Hold” by the eleven ratings firms that are currently covering the company, Stock Ratings News reports. Six investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $77.30.

Shares of CME Group (NYSE:CME) opened at 76.55 on Tuesday. CME Group has a 1-year low of $66.44 and a 1-year high of $84.71. The stock has a 50-day moving average of $73.97 and a 200-day moving average of $72.58. The company has a market cap of $25.722 billion and a price-to-earnings ratio of 26.77.

CME Group (NYSE:CME) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.77 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.79 by $0.02. The company had revenue of $731.60 million for the quarter, compared to the consensus estimate of $740.64 million. During the same quarter in the prior year, the company posted $0.93 earnings per share. The company’s quarterly revenue was down 10.4% on a year-over-year basis. On average, analysts predict that CME Group will post $3.18 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Thursday, September 25th. Shareholders of record on Wednesday, September 10th will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 2.46%. The ex-dividend date is Monday, September 8th.

CME has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of CME Group in a research note on Friday, August 1st. They now have a $78.00 price target on the stock. Separately, analysts at Barclays reiterated an “equal weight” rating on shares of CME Group in a research note on Friday, August 1st. They now have a $75.00 price target on the stock, down previously from $76.00. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of CME Group from $67.50 to $68.00 in a research note on Tuesday, July 8th. They now have a “neutral” rating on the stock.

CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.